TH1/TH17 cell recognition of desmoglein 3 and bullous pemphigoid antigen 180 in patients with lichen planus
Thomas Schmidt(Philipps University of Marburg), Michael Hertl(Universitätsklinikum Gießen und Marburg), Ronja Stein(Philipps University of Marburg), P Kind, Nicole B. Arweiler(Philipps University of Marburg), Cassian Sitaru(University of Freiburg), Farzan Solimani(Humboldt-Universität zu Berlin), Verena Eubel(Philipps University of Marburg), Robert Pollmann(Philipps University of Marburg), Inna Stulberg(Philipps University of Marburg), Katja Kühn(Philipps University of Marburg), Ansgar Schmidt(Philipps University of Marburg), Rüdiger Eming(Philipps University of Marburg)
Cited by 83
Related Papers
Consensus statement on definitions of disease, end points, and therapeutic response for pemphigus
|Journal of the American Academy of Dermatology|2008|586
Diagnosis and management of pemphigus: Recommendations of an international panel of experts
|Journal of the American Academy of Dermatology|2018|384
Definitions and outcome measures for bullous pemphigoid: Recommendations by an international panel of experts
|Journal of the American Academy of Dermatology|2011|370
Updated S2K guidelines on the management of pemphigus vulgaris and foliaceus initiated by the european academy of dermatology and venereology (EADV)
|Journal of the European Academy of Dermatology and Venereology|2020|332
Updated<scp>S2</scp>K guidelines for the management of bullous pemphigoid initiated by the European Academy of Dermatology and Venereology (<scp>EADV</scp>)
|Journal of the European Academy of Dermatology and Venereology|2022|247